Search results for "antiplatelet agents"
Alternative antiplatelet agents, alone or as adjunct, more effective than continuing aspirin monotherapy after new ischemic stroke
While the study may support the idea that alternative antiplatelet strategies are better than continued aspirin monotherapy in patients who have a stroke while on aspirin, with respect to stroke recurrence alone, switching to other antiplatelet agents was nominally but not statistically more effective than maintaining aspirin monotherapy.
https://immattersacp.org/weekly/archives/2015/12/08/6.htm
8 Dec 2015
Optimizing medical therapy after stroke
Stroke survivors often leave the hospital with new prescriptions and substantial confusion about how, or even whether, to take them. This leaves internists with the sometimes formidable job of evaluating, prescribing, or tweaking these regimens, identifying and managing adverse effects, and reinforcing education about treatment risks, benefits, and adherence.
https://immattersacp.org/archives/2016/06/stroke.htm
1 Jun 2016
Adding antiplatelet agents to dabigatran, warfarin elevates major bleeding risk
The risk of major bleeding is increased when antiplatelet drugs are added to either dabigatran or warfarin, a new subgroup analysis confirmed.
https://immattersacp.org/weekly/archives/2013/01/08/6.htm
8 Jan 2013
MKSAP Quiz: Elevated INR found on routine monitoring
A 75-year-old man is evaluated for an elevated INR found on routine monitoring. He is otherwise well and has no evidence of bleeding. Following lab studies and stopping warfarin, what is the most appropriate additional management?
https://immattersacp.org/weekly/archives/2022/09/27/3.htm
27 Sep 2022
New drugs for diabetes, secondary prevention of CV events
This update covers approval of a new drug to treat type 2 diabetes mellitus, along with diet and exercise, and of a drug to reduce risk of heart attack, stroke, cardiovascular death, and need for revascularization in patients with a previous heart attack or peripheral artery disease.
https://immattersacp.org/archives/2014/07/fda.htm
1 Jul 2014
Cardiovascular medications underused in Hispanic/Latino patients with PAD
Efforts to improve peripheral artery disease (PAD) treatment in Hispanic/Latino populations are needed, including improved access to health care and more guideline-adherent treatment, according to the authors of a recent study.
https://immattersacp.org/weekly/archives/2020/08/11/5.htm
11 Aug 2020
Target preop visits for efficiency, best outcomes
Internists can guide preoperative anticoagulation, ensure that patients are in optimal condition for procedures, and##mdash;perhaps most importantly##mdash;judiciously choose which tests to perform and which ones aren't needed.
https://immattersacp.org/archives/2014/09/preop.htm
1 Sep 2014
Oral anticoagulants and antiplatelets compared for risk of recurrent VTE, major bleeds
All oral anticoagulants and antiplatelet agents reduced recurrence of venous thromboembolism (VTE) compared with placebo, with aspirin reducing risk the least and vitamin K antagonists reducing it the most, a meta-analysis found.
https://immattersacp.org/weekly/archives/2013/09/10/5.htm
10 Sep 2013
New-generation anticoagulants associated with bleeding after ACS in patients on antiplatelet therapy
New-generation anticoagulants are associated with increased bleeding risk when used after acute coronary syndrome (ACS) in patients taking antiplatelet agents, according to a new meta-analysis.
https://immattersacp.org/weekly/archives/2012/10/02/5.htm
2 Oct 2012
Harms of antiplatelet therapy may outweigh benefits in chronic kidney disease
Antiplatelet therapy may have uncertain benefits that could be outweighed by bleeding risk in patients with chronic kidney disease, according to a new study.
https://immattersacp.org/weekly/archives/2012/03/20/6.htm
20 Mar 2012